13F Pro quality score
Rank #2,678 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from cbdMD, Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $19.2M | $-2.0M | -11.3% |
| FY 2024 | 10-K | $19.5M | $-3.7M | -17.0% |
| FY 2023 | 10-K | $24.2M | $-22.9M | -93.1% |
| FY 2022 | 10-K | $35.4M | $-70.1M | — |
| FY 2021 | 10-K | $44.5M | $-23.4M | -44.1% |
| FY 2020 | 10-K | $41.9M | $12.6M | -42.0% |
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
cbdMD, Inc. (YCBD) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores YCBD at 23.9/100 on a composite quality score built from its SEC filings, placing it at rank #2,678 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q3 2026), cbdMD, Inc. reports quarterly revenue of $5.6M, net income of $-1.1M, an operating margin of -20.4%. Top institutional holders of YCBD by reported 13-F value include CSS, VANGUARD CAPITAL MANAGEMENT, CHAPIN DAVIS, based on the most recent SEC filings. YCBD trades on the NYSE exchange and files with the SEC under CIK 1644903. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate YCBD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for cbdMD, Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1644903 →